Neurotoxicity: Clinical Trials

6 trials for Neurotoxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 terminated. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Recruiting 1, Terminated 1

Follow Neurotoxicity: new trials by email Literature Review of Neurotoxicity trials Research Report on Neurotoxicity

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release Oral Tablet - Liver Transplantation, Immunosuppression
Phase 4RecruitingUniversity of British Columbia1242023-01-092024-01-02
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
anti-pseudomonal cephalosporin, anti-pseudomonal penicillin - Sepsis, AKI
Phase 4CompletedVanderbilt University Medical Center26342021-11-102023-12-22
Envarsus Neurotoxicity Burden in Liver Transplant Patients
Envarsus, Tacrolimus Immediate release - Neurotoxicity, Liver Transplant; Complications
Phase 4CompletedMedical University of South Carolina302020-01-312025-03-30
Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients
Envarsus, IR Tacrolimus - Kidney Transplant; Complications, Toxicity
Phase 4CompletedUniversity of California, Davis642018-04-012025-04-08
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
ERIBULIN MESYLATE - Metastatic Breast Cancer, Toxicity
Phase 4CompletedOncologia Medica dell'Ospedale Fatebenefratelli2002014-05-012021-03-04
L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer
L-carnitine L-tartrate, placebo - Breast Cancer, Chemotherapeutic Agent Toxicity
Phase 4TerminatedHealthPartners Institute22007-01-022017-09-11

Narrower conditions

Neurotoxicity Syndromes (6)  ·  Breast Neoplasms (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)  ·  Sepsis (1)  ·  Tremor (1)

Broader conditions

Chemically-Induced Disorders (6)  ·  Nervous System Diseases (6)  ·  Poisoning (6)  ·  Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Dyskinesias (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)

Interventions

Tacrolimus (3)  ·  Carnitine (1)  ·  eribulin (1)

Sponsors

HealthPartners Institute (1)  ·  Medical University of South Carolina (1)  ·  Oncologia Medica dell'Ospedale Fatebenefratelli (1)  ·  University of British Columbia (1)  ·  University of California, Davis (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (4)  ·  Canada (1)  ·  Italy (1)

Top investigators

Alice Shapiro, PhD (1)  ·  Derek Dubay, MD (1)  ·  Edward T Qian, MD (1)  ·  Giovanna Damia, PHD (1)  ·  Jo-Ann Ford, RN (1)  ·  Ling-Xin Chen, MD (1)  ·  Trana Hussaini, Pharm D (1)

Results publications

PMID 36307826, PMID 36898748, PMID 37837651, PMID 41089174